Midatech Pharma plc is a biotechnology business based in the US. Midatech Pharma shares (MTP) are listed on the NASDAQ and all prices are listed in US Dollars. Midatech Pharma employs 18 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Midatech Pharma
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MTP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Midatech Pharma stock price (NASDAQ: MTP)Use our graph to track the performance of MTP stocks over time.
Midatech Pharma shares at a glance
|Latest market close||$1.91|
|52-week range||$1.60 - $3.55|
|50-day moving average||$2.09|
|200-day moving average||$2.20|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.85|
Buy Midatech Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Midatech Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Midatech Pharma price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||-12.79%|
|3 months (2021-04-30)||-3.54%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
Midatech Pharma financials
|Gross profit TTM||$-3,985,000|
|Return on assets TTM||-25.21%|
|Return on equity TTM||-168.89%|
|Market capitalisation||$38.2 million|
TTM: trailing 12 months
Shorting Midatech Pharma shares
There are currently 274,609 Midatech Pharma shares held short by investors – that's known as Midatech Pharma's "short interest". This figure is 18% down from 334,703 last month.
There are a few different ways that this level of interest in shorting Midatech Pharma shares can be evaluated.
Midatech Pharma's "short interest ratio" (SIR)
Midatech Pharma's "short interest ratio" (SIR) is the quantity of Midatech Pharma shares currently shorted divided by the average quantity of Midatech Pharma shares traded daily (recently around 4.6 million). Midatech Pharma's SIR currently stands at 0.06. In other words for every 100,000 Midatech Pharma shares traded daily on the market, roughly 60 shares are currently held short.
However Midatech Pharma's short interest can also be evaluated against the total number of Midatech Pharma shares, or, against the total number of tradable Midatech Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Midatech Pharma's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Midatech Pharma shares in existence, roughly 30 shares are currently held short) or 0.0304% of the tradable shares (for every 100,000 tradable Midatech Pharma shares, roughly 30 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Midatech Pharma.
Find out more about how you can short Midatech Pharma stock.
Midatech Pharma share dividends
We're not expecting Midatech Pharma to pay a dividend over the next 12 months.
Have Midatech Pharma's shares ever split?
Midatech Pharma's shares were split on a 1:5 basis on 2 March 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Midatech Pharma shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Midatech Pharma shares which in turn could have impacted Midatech Pharma's share price.
Midatech Pharma share price volatility
Over the last 12 months, Midatech Pharma's shares have ranged in value from as little as $1.6 up to $3.547. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Midatech Pharma's is 1.679. This would suggest that Midatech Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Midatech Pharma overview
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom. .
Stocks similar to Midatech Pharma
Midatech Pharma in the news
Midatech Pharma PLC Announces Appointment of Chief Scientific Officer
EXECUTIVE CHANGES: MP Evans CEO Price departs after 15 years
Midatech Pharma Appoints New Chief Scientific Officer
Frequently asked questionsWhat percentage of Midatech Pharma is owned by insiders or institutions?
Currently 0.135% of Midatech Pharma shares are held by insiders and 7.702% by institutions. How many people work for Midatech Pharma?
Latest data suggests 18 work at Midatech Pharma. When does the fiscal year end for Midatech Pharma?
Midatech Pharma's fiscal year ends in December. Where is Midatech Pharma based?
Midatech Pharma's address is: Oddfellows House, Cardiff, United Kingdom, CF24 0AA What is Midatech Pharma's ISIN number?
Midatech Pharma's international securities identification number is: US59564R3021 What is Midatech Pharma's CUSIP number?
Midatech Pharma's Committee on Uniform Securities Identification Procedures number is: 59564R104
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert